Codexis is a biotech company trying to turn cellulosic biomass into fuel. It was spun off from Maxygen in 2010.


Updates from The Motley Fool

Latest updates on Codexis from Fool.com.


Stock Performance

CDXS vs. S&P 500 | 2 Year Performance
View Interactive CDXS Charts
Sponsored by

Key Data Points

Primary metrics and data points about Codexis .
Current Price: $4.44
Prev Close: $4.27
Open: $4.25
Bid: $4.11
Ask: $4.50
Day's Range: $4.25 - $4.48
52wk Range: $2.93 - $4.63
Volume: 104,170
Avg Vol 74,781
Market Cap: $179M
P/E (ttm): 12.20
EPS (ttm): $0.35
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Codexis .
CAPS Rating 2 out of 5
 
42 Outperform
7 Underperform
CAPS All Stars
 
8 Outperform
3 Underperform

How do you think Codexis will perform against the market?



You pick for Codexis is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John J. Nicols, CEO

48% Approve

Based on 19 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Codexis .

Codexis is a biotech company trying to turn cellulosic biomass into fuel. It was spun off from Maxygen in 2010.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers